menu search

Bud light stock surges on earnings; is the boycott finally over?

In the wake of a challenging couple of months marked by declining sales and tumbling stock price, the shares of Bud Light owner Anheuser-B...

October 31, 2023, 11:33 am

Sarepta stock sinks on mixed gene therapy results

In a gene therapy study for patients with Duchenne muscular dystrophy, the primary endpoint was not met...

October 31, 2023, 8:01 am

Ab inbev price hikes helps offset bud light boycott

Anheuser-Busch InBev (NYSE:BUD), the owner of Bud Light and Stella Artois, trundled over 3% higher on T...

October 31, 2023, 5:45 am

Bud light controversy continues to weigh on anheuser-busch inbev

The Bud Light controversy continued to weigh on Anheuser-Busch InBev, which nonetheless managed a small...

October 31, 2023, 4:50 am

Lattice semiconductor corporation (lscc) q3 2023 earnings call transcript

Lattice Semiconductor Corporation (NASDAQ:LSCC ) Q3 2023 Earnings Conference Call October 30, 2023 5:00 PM ET Company Participants James Anderson - Pr...

October 30, 2023, 11:15 pm

Sarepta therapeutics stock halted after unveiling mixed results for its first gene therapy

Sarepta unveiled mixed results late Monday for a gene therapy that targets a muscle-wasting disease in ...

October 30, 2023, 5:52 pm

Sarepta's gene therapy fails to meet primary goal in rare muscular dystrophy trial

Sarepta Therapeutics' gene therapy to treat Duchenne muscular dystrophy failed to reach statistical sig...

October 30, 2023, 4:11 pm

Reneo pharmaceuticals: buy before upcoming pivotal data drop

Reneo Pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavodelpar or REN001. Mavodelpar has shown promising ...

October 29, 2023, 8:00 pm

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of nuscale power corporation – smr

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of N...

October 27, 2023, 7:55 pm

Eni s.p.a. (e) q3 2023 earnings call transcript

Eni S.p.A. (NYSE:E ) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Francesco Gattei - Chief Financial Officer Cris...

October 27, 2023, 12:42 pm

L3harris technologies, inc. (lhx) q3 2023 earnings call transcript

L3Harris Technologies, Inc. (NYSE:LHX ) Q3 2023 Earnings Conference Call October 27, 2023 8:30 AM ET Corporate Participants Mark Kratz - Vice Presiden...

October 27, 2023, 11:40 am

Enphase energy downgraded to neutral at oppenheimer on uncertainty in solar industry

Enphase Energy Inc. ENPH, +1.94% drew a downgrade to perform from outperform by Oppenheimer analyst Colin Rusc...

October 27, 2023, 9:02 am

Enphase energy, inc. (enph) q3 2023 earnings call transcript

Enphase Energy, Inc. (NASDAQ:ENPH ) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET Company Participants Zach Freedman - IR Badri Kothand...

October 26, 2023, 9:32 pm

Catalyst pharmaceuticals reports fda approval of agamree® (vamorolone) for duchenne muscular dystrophy granted to santhera pharmaceuticals

AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Ol...

October 26, 2023, 7:19 pm

Paxmedica’s research on low dose suramin for autism spectrum disorder accepted for publication

TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) — via IBN — PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited...

October 26, 2023, 5:51 pm

Idex corporation (iex) q3 2023 earnings call transcript

IDEX Corporation (NYSE:IEX ) Q3 2023 Results Conference Call October 26, 2023 10:30 AM ET Company Participants Allison Lausas - Interim CFO & CAO Eric...

October 26, 2023, 4:58 pm

The usd is the strongest and the eur is the weakest as the na session begin..

The USD is the strongest and the EUR is the weakest as the NA session begins. The major currencies ranking are showing relatively scrunched together. ...

October 26, 2023, 12:10 pm

Scholar rock: sma data readout in 2024 makes this worth a look

The Scholar Rock Holding Corporation phase 3 SAPPHIRE study for apitegromab for the treatment of type 2 and type 2 SMA patients has completed enrollme...

October 25, 2023, 5:44 pm

Aces: not the time and disappointing performance

The performance of the ALPS Clean Energy ETF has been subpar compared to its peers in the clean energy sector. The clean energy sector is highly s...

October 25, 2023, 12:36 pm

Anheuser-busch: the pain could be worse as the recovery has fizzled out

AB InBev investors have seen little relief as the consumer staples sector weakened recently, impacting BUD's recovery. The company's ex-US market mome...

October 25, 2023, 12:30 pm


Search within

Pages Search Results: